Yi Zhong Selected Research

3- chloro- 2- methyl- N- (4- (2- (4- methyl- 1- piperazinyl)- 2- oxoethyl)- 1,3- thiazol- 2- yl)benzenesulfonamide

1/2012	BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
1/2011	Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
11/2008	[Mechanism of BVT.2733 and pioglitazone in the improvement of insulin resistance].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi Zhong Research Topics

Disease

53	Neoplasms (Cancer) 11/2022 - 12/2007
15	Inflammation (Inflammations) 01/2022 - 10/2005
13	Squamous Cell Carcinoma of Head and Neck 01/2022 - 09/2014
13	Neoplasm Metastasis (Metastasis) 10/2021 - 11/2012
11	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 04/2004
10	Pain (Aches) 07/2022 - 08/2008
9	Carcinogenesis 01/2021 - 02/2002
7	Ischemic Stroke 01/2022 - 01/2018
7	Schizophrenia (Dementia Praecox) 06/2021 - 11/2011
7	Infections 01/2021 - 09/2008
6	Intervertebral Disc Displacement (Herniated Disc) 05/2022 - 01/2017
6	Insulin Resistance 01/2021 - 11/2008
6	Body Weight (Weight, Body) 01/2021 - 11/2008
5	Obesity 01/2022 - 01/2011
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 11/2014
4	Carcinoma (Carcinomatosis) 02/2022 - 02/2011
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2010
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 11/2006
4	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2010
4	Presbycusis 07/2015 - 07/2010
3	Chronic Pain 07/2022 - 01/2017
3	Fibrosis (Cirrhosis) 01/2022 - 01/2020
3	Reperfusion Injury 01/2021 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2020
3	Wounds and Injuries (Trauma) 10/2020 - 10/2017
3	COVID-19 07/2020 - 01/2020
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2011
3	Mental Disorders (Mental Disorder) 01/2018 - 11/2011
3	Vesicular Stomatitis 02/2017 - 04/2015
3	Memory Disorders (Memory Loss) 10/2012 - 04/2010
2	Colonic Neoplasms (Colon Cancer) 11/2022 - 12/2010
2	Brain Ischemia (Cerebral Ischemia) 07/2022 - 01/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2022 - 03/2012
2	Colitis 01/2022 - 03/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
2	Pruritus (Itching) 01/2022 - 11/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2022
2	Lymphoma (Lymphomas) 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Exanthema (Rash) 01/2022 - 03/2017
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2022 - 04/2006

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2002
11	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 11/2008
10	RNA (Ribonucleic Acid)IBA 09/2021 - 04/2015
9	Messenger RNA (mRNA)IBA 10/2021 - 01/2011
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
7	CytokinesIBA 11/2022 - 07/2011
7	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2007
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
6	Peptides (Polypeptides)IBA 01/2019 - 04/2004
5	Oxygen (Dioxygen)IBA 07/2022 - 12/2014
5	Phosphotransferases (Kinase)IBA 07/2022 - 12/2010
5	EnzymesIBA 06/2021 - 07/2008
5	ChromatinIBA 01/2021 - 03/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2012
4	CateninsIBA 01/2022 - 01/2020
4	Biological ProductsIBA 10/2021 - 01/2017
4	Uric Acid (Urate)IBA 01/2020 - 01/2019
4	Amyloid (Amyloid Fibrils)IBA 10/2019 - 07/2008
4	Oxidoreductases (Dehydrogenase)IBA 01/2013 - 01/2011
3	Dexmedetomidine FDA Link 12/2022 - 09/2020
3	Interleukin-6 (Interleukin 6)IBA 11/2022 - 10/2019
3	Fluorouracil (Carac)FDA LinkGeneric 11/2022 - 02/2011
3	AcidsIBA 07/2022 - 10/2005
3	Long Noncoding RNAIBA 06/2022 - 01/2020
3	IronIBA 06/2022 - 11/2006
3	Therapeutic UsesIBA 05/2022 - 10/2005
3	InflammasomesIBA 01/2022 - 01/2019
3	Hormones (Hormone)IBA 01/2022 - 03/2017
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2012
3	CreatinineIBA 01/2022 - 01/2019
3	bushen jianpiIBA 01/2021 - 02/2011
3	VaccinesIBA 01/2021 - 09/2008
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 08/2008
3	Oncogene Proteins (Oncogene Protein)IBA 10/2020 - 09/2014
3	GlucocorticoidsIBA 01/2020 - 01/2012
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2012
3	LipidsIBA 01/2020 - 01/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2020 - 07/2011
3	src-Family KinasesIBA 10/2019 - 08/2010
3	Amyloid beta-PeptidesIBA 01/2018 - 04/2004
3	ORALIT (ORS)IBA 01/2017 - 01/2016
3	Galactose (Galactopyranose)FDA LinkGeneric 07/2015 - 07/2010
3	3- chloro- 2- methyl- N- (4- (2- (4- methyl- 1- piperazinyl)- 2- oxoethyl)- 1,3- thiazol- 2- yl)benzenesulfonamideIBA 01/2012 - 11/2008
3	ferric nitrilotriacetateIBA 01/2009 - 11/2006
2	InterleukinsIBA 11/2022 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 07/2022 - 12/2018
2	Nitric Oxide Synthase (NO Synthase)IBA 07/2022 - 12/2012
2	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2022
2	MelatoninIBA 05/2022 - 01/2022
2	apatinibIBA 01/2022 - 01/2022
2	GlycopeptidesIBA 01/2022 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
2	ChemokinesIBA 01/2022 - 01/2021

Therapy/Procedure

23	Therapeutics 06/2022 - 10/2010
6	Drug Therapy (Chemotherapy) 01/2022 - 09/2008
3	Immunotherapy 02/2022 - 03/2017
3	Tracheostomy 07/2020 - 01/2020
2	Intraperitoneal Injections 11/2022 - 01/2022